#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15940	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2567	749.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	2035	2035	T	1053	T,G,A	1051,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15940	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2567	749.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1769	1769	C	1010	C	1010	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27496	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4333	792.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	2045	2045	A	1146	A	1146	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27496	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4333	792.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2679	2679	C	968	C,T	966,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27496	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4333	792.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2753	2753	A	878	A	878	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27496	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4333	792.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3305	3305	C	929	C,T	928,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2394	folP	855	855	100.0	folP.l6.c4.ctg.1	2236	133.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1423	1425	AGC	264;263;263	A,G;G;C	263,1;263;263	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5452	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3988	170.7	1	SNP	p	S91F	1	.	.	271	273	TTC	918	920	TTC	212;212;211	T;T;C	212;212;211	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5452	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3988	170.7	1	SNP	p	G95N	0	.	.	283	285	GGC	930	932	GGC	218;217;215	G;G;C	218;217;215	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5452	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3988	170.7	1	SNP	p	D95G	1	.	.	283	285	GGC	930	932	GGC	218;217;215	G;G;C	218;217;215	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2162	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1971	137.0	1	SNP	p	G45D	0	.	.	133	135	GGC	785	787	GGC	251;250;249	G,T;G;C	250,1;250;249	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1178	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1364	106.9	0	.	n	.	0	A197.	DEL	197	197	A	788	788	A	221	A	221	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1715	1717	GTC	232;231;230	G,T;T,C;C	230,2;230,1;230	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	1	SNP	p	D86N	0	.	.	256	258	GAC	821	823	GAC	235;239;239	G;A,G;C	235;238,1;239	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	1	SNP	p	S87R	1	.	.	259	261	CGT	824	826	CGT	242;241;240	C;G;T	242;241;240	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	1	SNP	p	R87I	0	.	.	259	261	CGT	824	826	CGT	242;241;240	C;G;T	242;241;240	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	1	SNP	p	R87W	0	.	.	259	261	CGT	824	826	CGT	242;241;240	C;G;T	242;241;240	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5102	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3475	183.2	1	SNP	p	S88P	0	.	.	262	264	TCC	827	829	TCC	238;238;241	T;C;C	238;238;241	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4742	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3177	186.3	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1554	1556	TGC	255;256;257	T;G;C	255;256;257	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4742	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3177	186.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1764	1766	GGC	252;253;250	G;G;C	252;253;250	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	260;263;267	G;C,T;A,T	260;262,1;266,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	266;262;265	A,T;T,C;C	265,1;261,1;265	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	267;271;273	G;T;G	267;271;273	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	267;271;273	G;T;G	267;271;273	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	253;254;255	A;C;C,A,T	253;254;253,1,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	251;248;244	G;C;G	251;248;244	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	251;248;244	G;C;G	251;248;244	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2161	2163	GGC	235;234;235	G;G;C	235;234;235	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	243;243;246	G;G;C	243;243;246	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4378	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2923	186.7	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2188	2190	TCG	236;235;237	T,C;C,A;G,A	234,2;234,1;236,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6036	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3565	210.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1864	1866	CCG	247;245;243	C,T;C,G;G	246,1;244,1;243	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2866	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2537	141.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	902	902	C	216	C	216	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	36.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	17;18;20	T;T;A	17;18;20	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	36.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	46;46;46	C;A;T	46;46;46	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	36.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	46;46;46	A;G;T	46;46;46	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	36.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	46;46;46	T;A;C	46;46;46	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	59.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	67;65;64	A;C;G	67;65;64	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	294	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	59.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	22;21;17	C;A;A	22;21;17	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	618	620	GAA	257;257;261	G,C;A;A	256,1;257;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	906	908	GAT	240;239;238	G;A;T	240;239;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1029	1031	TCA	282;281;284	T;C;A	282;281;284	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1158	1160	GTC	255;256;255	G;T;C	255;256;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1488	1490	GCA	206;206;207	G;C,A;A	206;204,2;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	0	.	p	.	0	D333V	NONSYN	997	999	GAC	1503	1505	GTC	201;202;203	G;T;C	201;202;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	1	SNP	p	G120K	1	.	.	358	360	AAG	864	866	AAG	249;252;251	A;A;G,T	249;252;250,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	1	SNP	p	D121N	0	.	.	361	363	GAC	867	869	GAC	253;252;252	G,T,A;A,T;C,T	251,1,1;251,1;251,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3012	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1688	215.2	1	SNP	p	A121D	1	.	.	361	363	GAC	867	869	GAC	253;252;252	G,T,A;A,T;C,T	251,1,1;251,1;251,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10500	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5478	239.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2366	2368	AAT	277;279;279	A,C;A;T	276,1;279;279	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1530	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1509	125.8	1	SNP	p	V57M	1	.	.	169	171	ATG	715	717	ATG	267;267;267	A;T;G	267;267;267	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
